Disappearance of cystinuria after renal transplantation.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to F J Trijbels.
Explore the source record for details and available documents.
Fasting homocystinemia in homocystinuria due to cystathionine synthase deficiency reportedly disappears on high-dose pyridoxine treatment. This does not necessarily reflect normal tolerance to methionine. The present study compares the effects of oral methionine loading on homocystine, cystine, and homocysteine-cysteine disulphide profiles in 8 adult homozygous homocystinuria patients on and off pyridoxine treatment and in 20 controls. Pyridoxine nearly normalized fasting serum amino acid levels. Nevertheless, with a similar methionine load the patient's homocystine levels on and off treatment rose and the cystine levels decreased, reflecting the ongoing formation of the homocysteine-cysteine disulphide in the presence of impaired transsulphuration of homocysteine. In the controls homocystinemia remained virtually absent and cystine transiently rose which indicates normal transsulphuration. On treatment methionine loading evoked a brisk rise of the homocysteine-cysteine disulphide levels to values equal to those off treatment, when these levels virtually plateaued after the load. Thus, pyridoxine treatment attenuates the biochemical abnormalities in the fasting patients but leaves their impaired capacity to handle major methionine loads essentially unchanged.
Premenopausal women develop occlusive artery disease less frequently than postmenopausal women. In coronary heart disease, higher blood levels of homocysteine-cysteine mixed disulphide have been reported. Therefore, in healthy subjects, we studied the role of menopausal status in the transsulphuration of methionine in 10 premenopausal and 10 postmenopausal women. To exclude the role of aging, we compared these results with those in 10 younger and 10 older men of comparable age groups. An oral methionine load (0.1 g/kg of body weight) was administered after overnight fasting. Before and during 8 h, thereafter, serum levels of methionine, homocystine, and homocysteine-cysteine mixed disulphide were measured. In the fasting state, serum methionine levels were similar in the premenopausal women and both groups of men. Postmenopausal women had significantly lower fasting levels. Peak levels and clearances of methionine after loading did not differ between the groups. In the fasting state, homocystine was never detectable; yet, after methionine loading, slight homocystinemia was present in 12 out of 20 men, and was more pronounced in all postmenopausal women. However, homocystinemia did not occur in any of the premenopausal women after loading. Fasting serum homocysteine-cysteine mixed disulphide levels did not differ between both groups of men and postmenopausal women. In premenopausal women, both fasting and postloading disulphide levels were significantly lower than in any other group. We conclude that premenopausal women have a unique efficiency of methionine handling, and thereby are preserved against the accumulation of homocysteine after methionine loading. We speculate that this phenomenon might account for the lower incidence of vascular disease in women in the reproductive life cycle.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
We measured pyruvate oxidation in intact leukocytes and fibroblasts by measuring 14C02 production. The optimal pyruvate concentration appeared to be higher than that usually applied. Activities remained constant during the incubation and were proportional to the amount of tissue protein added. Man values (+/-SD) were 2.8 +/- 0.9 nmol/h per 10(6) cells and 37 +/- 14 nmol/h per mg of protein for leukocytes and fibroblasts, respectively, for [1-14C]pyruvate oxidation; and 2.1 +/- 0.8 nmol/h per 10(6) cells and 18 +/- 7 nmol/h per mg of protein, respectively for [2-14C]pyruvate oxidation. We compared oxidation rates of pyruvate and 2-oxoglutarate by intact cells with those of isolated mitochondria. The ratio of 14CO2 production vs. activity of mitochondrial marker enzyme demonstrated that the rate of pyruvate oxidation can adequately be assayed in intact cells, but that the permeability of the cell membrane is rate-limiting in the oxidation of 2-oxoglutarate. No significant oxidation of other intermediates of the citric acid cycle was found, presumably owing to a low rate of transport of these substances across the cell membrane.
Explore the source record for details and available documents.
Severe methylenetetrahydrofolate reductase (MTHFR) deficiency is an inborn error of folate metabolism, and is inherited as an autosomal recessive trait. MTHFR is a key enzyme in folate-dependent remethylation of homocysteine, and reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. Patients with this severe enzymatic deficiency are biochemically characterised by homocystinuria and hypomethioninaemia, and may suffer from neurological abnormalities, mental retardation and premature vascular disease. Here we report the molecular basis of severe MTHFR deficiency in four unrelated families from Turkish/Greek ancestry. By use of reverse-transcriptase (RT)-PCR, subsequently followed by direct sequencing analysis, we were able to identify four novel mutations in the MTHFR gene: two missense (983A-->G; 1027T-->G) and two nonsense (1084C-->T; 1711C-->T) mutations. Furthermore, a splice variant containing a premature termination codon, was observed in one patient, probably as a secondary effect of the 1027T-->G missense mutation. The ongoing identification and characterisation of mutations in the MTHFR gene will provide further insight into the heterogeneity of the clinical phenotype in severe MTHFR deficiency.
Basement membrane collagen is relatively rich in hydroxylysine and the glycosides of hydroxylysine, glucosylgalactosylhydroxylysine and galactosylhydroxylysine. In this paper a modified procedure for analysis of these substances in urine is described, using a purification-step with the cation-exchange resin Amberlite CG-120 type II and a modified program for amino acid analysis. Values are obtained from 75 healthy persons of different ages ranging from prematurity to adulthood. The influence of maturation is studied. Prematures and young children have a high and rather variable excretion of all components, whereas adults have low and similar excretion rates. Neither the ratio glucosylgalactosylhydroxylysine/galactosylhydroxylysine nor the percentage of glycosylated hydroxylysine can be shown to be age-dependent. These data are important for the study of collagen disorders, especially in childhood.